Cargando…

Hypertonic Saline in Treatment of Pulmonary Disease in Cystic Fibrosis

The pathogenesis of lung disease in cystic fibrosis is characterised by decreased airway surface liquid volume and subsequent failure of normal mucociliary clearance. Mucus within the cystic fibrosis airways is enriched in negatively charged matrices composed of DNA released from colonizing bacteria...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reeves, Emer P., Molloy, Kevin, Pohl, Kerstin, McElvaney, Noel G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific World Journal 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356721/ https://www.ncbi.nlm.nih.gov/pubmed/22645424 http://dx.doi.org/10.1100/2012/465230

Ejemplares similares

An investigation of IL-8 degradation in response to PA401 compared to hypertonic saline in bronchoalveolar lavage fluid of Cystic Fibrosis patients
por: Kerr, H, et al.
Publicado: (2015)

The Involvement of Glycosaminoglycans in Airway Disease Associated with Cystic Fibrosis
por: Reeves, Emer P., et al.
Publicado: (2011)

Targeting IgG Autoantibodies for Improved Cytotoxicity of Bactericidal Permeability Increasing Protein in Cystic Fibrosis
por: McQuillan, Karen, et al.
Publicado: (2020)

Intracellular Secretory Leukoprotease Inhibitor Modulates Inositol 1,4,5-Triphosphate Generation and Exerts an Anti-Inflammatory Effect on Neutrophils of Individuals with Cystic Fibrosis and Chronic Obstructive Pulmonary Disease
por: Reeves, Emer P., et al.
Publicado: (2013)

The importance of CFTR expression for neutrophil function in patients with Cystic Fibrosis
por: Jundi, B, et al.
Publicado: (2015)

Animal Models of Cystic Fibrosis Pathology: Phenotypic Parallels and Divergences
por: Lavelle, Gillian M., et al.
Publicado: (2016)

Altered Degranulation and pH of Neutrophil Phagosomes Impacts Antimicrobial Efficiency in Cystic Fibrosis
por: Hayes, Elaine, et al.
Publicado: (2020)

Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Bergin, David A, et al.
Publicado: (2013)

Neutrophil Membrane Cholesterol Content is a Key Factor in Cystic Fibrosis Lung Disease
por: White, Michelle M., et al.
Publicado: (2017)

Impaired Airway Epithelial Barrier Integrity in Response to Stenotrophomonas maltophilia Proteases, Novel Insights Using Cystic Fibrosis Bronchial Epithelial Cell Secretomics
por: Molloy, Kevin, et al.
Publicado: (2020)

Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19
por: McElvaney, Oliver J, et al.
Publicado: (2021)

Hypertonic saline releases the attached small intestinal cystic fibrosis mucus
por: Ermund, Anna, et al.
Publicado: (2015)

The role of TIM-containing molecules in airway disease and their potential as therapeutic targets
por: Vega-Carrascal, Isabel, et al.
Publicado: (2012)

Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
por: Ribeiro, Carla Maria Pedrosa, et al.
Publicado: (2021)

Hypertonic saline in people with cystic fibrosis: review of comparative studies and clinical practice
por: Terlizzi, Vito, et al.
Publicado: (2021)

Stratified assessment of the role of inhaled hypertonic saline in reducing cystic fibrosis pulmonary exacerbations: a retrospective analysis
por: Dmello, Dayton, et al.
Publicado: (2011)

miR-224-5p and miR-545-5p Levels Relate to Exacerbations and Lung Function in a Pilot Study of X-Linked MicroRNA Expression in Cystic Fibrosis Monocytes
por: McKiernan, Paul J., et al.
Publicado: (2021)

Rheological effects of hypertonic saline and sodium bicarbonate solutions on cystic fibrosis sputum in vitro
por: Budai-Szűcs, Mária, et al.
Publicado: (2021)

Inhaled hypertonic saline in adults hospitalised for exacerbation of cystic fibrosis lung disease: a retrospective study
por: Pezzulo, Alejandro A, et al.
Publicado: (2012)

Acute inhalation of hypertonic saline does not improve mucociliary clearance in all children with cystic fibrosis
por: Laube, Beth L, et al.
Publicado: (2011)

Advances toward the Elucidation of Hypertonic Saline Effects on Pseudomonas aeruginosa from Cystic Fibrosis Patients
por: Michon, Anne-Laure, et al.
Publicado: (2014)

Dysregulated neutrophil function in individuals with alpha-1 antitrypsin deficiency caused by modified membrane cholesterol content.
por: Jundi, Bakr, et al.
Publicado: (2015)

Efficacy of hypertonic saline versus isotonic saline among children with cystic fibrosis: A systematic review and meta-analysis
por: Ullah, Saad Ehsan, et al.
Publicado: (2023)

The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals
por: Dunlea, Danielle M, et al.
Publicado: (2018)

miRNA-221 is elevated in cystic fibrosis airway epithelial cells and regulates expression of ATF6
por: Oglesby, Irene K, et al.
Publicado: (2015)

Comment on “Efficacy of hypertonic saline versus isotonic saline among children with cystic fibrosis: A systematic review and meta-analysis”
por: Gutierrez-Arias, Ruvistay, et al.
Publicado: (2023)

Characterisation of the Major Extracellular Proteases of Stenotrophomonas maltophilia and Their Effects on Pulmonary Antiproteases
por: Molloy, Kevin, et al.
Publicado: (2019)

Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency
por: O'Brien, Michael E, et al.
Publicado: (2020)

Targeting of Glycosaminoglycans in Genetic and Inflammatory Airway Disease
por: Caird, Robin, et al.
Publicado: (2022)

Cystic fibrosis disease severity correlates with plasma levels of desmosine and isodesmosine, biomarkers of elastin degradation
por: Ma, Shuren, et al.
Publicado: (2019)

Hypertonic Saline in the Treatment of Hemorrhagic Shock
por: Vahidi, Elnaz, et al.
Publicado: (2017)

Hypertonic saline solutions do not influence the solubility of sputum from secretor and non-secretor cystic fibrosis patients
por: Barboza, Marcelo A.I., et al.
Publicado: (2011)

Nebulized hypertonic saline triggers nervous system-mediated active liquid secretion in cystic fibrosis swine trachea
por: Luan, Xiaojie, et al.
Publicado: (2019)

COVID‐19 infection in an infant with cystic fibrosis: A case report and possible therapeutic effect of hypertonic saline
por: Seyedi, Seyed Javad, et al.
Publicado: (2022)

Hypertonic Saline Therapy in Cystic Fibrosis: Do Population Shifts Caused by the Osmotic Sensitivity of Infecting Bacteria Explain the Effectiveness of this Treatment?
por: Williams, Huw D., et al.
Publicado: (2010)

Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study
por: O'Neill, Katherine, et al.
Publicado: (2017)

Hypertonic saline resuscitation in sepsis
por: Wade, Charles E
Publicado: (2002)

Hypertonic Saline in Snake-Bite
por: Bhattacharyya, R. K.
Publicado: (1928)

Apparatus for the Treatment of Cholera by Hypertonic Saline Infusion
por: Rutherfoord, T. C.
Publicado: (1911)

Inhibition of Toll-Like Receptor 2-Mediated Interleukin-8 Production in Cystic Fibrosis Airway Epithelial Cells via the α7-Nicotinic Acetylcholine Receptor
por: Greene, Catherine M., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_4pviliqbncsa3sfpqd9g72fitg